While you are free to navigate all or part of this internet set, you are hereby informed and agree that any access and use of the Website on your part must comply with these terms and conditions of use and all applicable laws. The Website is available for use by Healthcare Professionals practicing in France. Any use of the contents and links to the contents on the Website that does not comply with these Terms of Use is prohibited.
1. Legal Notices
This internet site (the “Website”) is published by PFIZER, a Simplified Joint Stock Company with a capital of 47570 Euros registered with the Paris Trade and Companies Register under Number B 433 623 550, whose registered office is located at 23-25, avenue du Docteur Lannelongue 75014 Paris (“Pfizer”), the Lessee-Manager of PFIZER Holding France. Telephone: 01 58 07 30 00
The publication director is Mr Franck Le Breguero, Chief Pharmaceutical Officer.
The web host is the Acquia company, 53 State Street 10th Floor, Boston, MA 02109 USA, registered under Number 26-0493001. Telephone: +1 888-922-7842. The Website is hosted in Ireland, inside the European Economic Area.
2. Purpose and content of the Website
2.1 Nature and scope of the information provided on the Website
The purpose of the Website is to handle Medical Information requests in relation to medications and products of Pfizer’s France group company, operating in the field of pharmaceuticals. It contains medical information intended for healthcare professionals practicing in France.
The medical and pharmaceutical information available on this Website is intended for general information purposes in response to unsolicited medical questions from healthcare professionals practicing in France. The scientific content available on the Site is factual and precise, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to incorporate recent data.
The user hereby acknowledge he/she is fully informed that the information contained on the Website is not in any manner whatsoever provided for the purpose of:
2.2 Updates to the Website
Pfizer will make its best effort to offer up-to-date information on the Website. However, some information that is offered may require updating that the company might be unable to provide prior to the time when it is consulted by the user. Pfizer may not be held liable for any errors or omissions.
2.3 Hyperlinks
Links to third‑party websites.
The Website may provide links to other sites whose contents are not controlled by Pfizer. Access and use of these sites is made at the full and sole liability of the user, according to the terms and conditions of use that may potentially apply for such third party websites.
Links point to the Website.
Simple hyperlinks to publicly accessible pages of the Site may be created, provided that:
Pfizer reserves the right to request the removal of any link that does not comply with the foregoing conditions or otherwise infringes Pfizer's rights, and to pursue any remedies available under applicable law.
3. Intellectual Property
The Website and in particular all of its individual elements taken separately, artwork, displayed information, static or moving images, sounds, graphic design, the contents of any and all articles, press reviews, and more generally all information appearing on the Website are the exclusive property of Pfizer or third parties with whom Pfizer has signed agreements allowing for reproduction and distribution.
Subject to the exceptions provided for in the French Intellectual Property Code, all reproduction, distribution and more generally all exploitation, in all or in part, of the Website are subject to the prior express written authorisation from Pfizer.
Any and all use of data or information taken from the Website duly authorised by Pfizer must contain a comment indicating Pfizer or the person or entity as author of the information, as source of the information The names and logos that are the property of Pfizer and in particular any names and logos potentially associated with the Website constitute protected registered trademarks. Any use of such names and/or logos require prior express written authorisation from Pfizer.
You are expressly prohibited from using robots, spiders, scripts, service, software or any manual or automatic device, tool, or process designed to data mine or scrape any content from this Website, or otherwise use, access, or collect any content using automated means, except for purposes of indexing for inclusion in a public search engine.
4. Responsibility
The Website is in principle available 24 hours a day, 7 days a week, except in cases of force majeure or events beyond the control of the publisher of the Site and subject to any breakdowns or maintenance interventions necessary for the proper functioning of the Site. The publisher of the Website also reserves the right to modify, suspend, restrict or interrupt access to all or part of the Website, without notice. The responsibility of the publisher of the Website cannot therefore be sought for temporary or permanent unavailability, total or partial of the Website.
The user is solely responsible for the use he makes of the Website. As an express reminder, the Internet is not a secure network. It is up to the users to take all appropriate measures to protect their hardware and the data stored on their hardware against any infringement. Pfizer denies any liability in the event of damage incurred by the user and such damage may not be attributed to Pfizer, in particular as a result of the loss, degradation or corruption of files, the transmission of viruses infecting the user’s computer equipment or any other property occurring while connected and/or consulted and/or making use of the Website.
5. Pharmacovigilance
Any reportable adverse effects linked to a Pfizer product must be immediately sent via the portal Déclaration des manifestations indésirables de Pfizer or via email to FRA.AEReporting@pfizer.com.
6. Applicable Law
The Website is governed by French law.
7. Updates
These terms and conditions of use may be subject to updates by Pfizer. For this reason, we encourage you to keep yourself regularly informed of the Website’s terms and conditions of use.